Extraction-Free Pathogen Testing With Direct PCR Buffer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PCR methods for infectious disease detection require a laborious and expensive nucleic acid extraction step, increasing the risk of contamination and human error, and are hindered by supply shortages during high demand periods.
Innovation Solution
A unique buffer composition is used to process biological samples directly for nucleic acid amplification and analysis without initial extraction, allowing for direct use of nucleic acid in qPCR, rtPCR, and NGS-based testing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If nucleic acid extraction and purification steps are performed as in conventional PCR methods, then detection accuracy is maintained, but the process becomes laborious, expensive, and time-consuming
Solution Approach 1:
The invention extracts and removes the nucleic acid extraction and purification steps from the conventional PCR workflow. By using a buffer system that allows direct PCR amplification from crude clinical samples, the method eliminates the time-consuming and labor-intensive extraction process while maintaining detection accuracy through optimized buffer composition and direct amplification protocols
Solution Approach 2:
The invention merges the sample collection, nucleic acid preservation, and PCR amplification steps into a single integrated workflow. The unique buffer composition serves multiple functions simultaneously: preserving nucleic acids in crude samples, enabling direct amplification, and maintaining detection sensitivity, thereby combining what were previously separate sequential steps into a unified process
2Reliability
If multiple manual extraction steps are performed, then nucleic acid quality is improved, but the risk of contamination and human error increases
Solution Approach 1:
The invention enables the sample to serve itself by designing a buffer system that allows crude clinical samples to undergo direct PCR amplification without requiring manual extraction interventions. The buffer composition is engineered to preserve nucleic acids and enable direct amplification, eliminating the need for human-operated extraction steps that introduce contamination risks
Solution Approach 2:
The unique buffer composition acts as an intermediary substance that mediates between the crude clinical sample and the PCR amplification process. This buffer system provides the necessary chemical environment for direct amplification while protecting the nucleic acids from degradation and contamination, serving as a protective intermediary that eliminates manual handling steps
3Measurement precision
If comprehensive nucleic acid purification is performed, then detection sensitivity is maintained, but the cost of consumables and labor increases
Solution Approach 1:
The invention replaces expensive, complex extraction kits and consumables with a simple, inexpensive buffer system that enables direct PCR amplification. The buffer composition uses cost-effective reagents that provide sufficient nucleic acid preservation and amplification conditions without requiring expensive purification columns, spin filters, or other costly extraction consumables
Solution Approach 2:
The invention changes the chemical parameters of the sample processing system by using a specifically formulated buffer composition with optimized pH, ionic strength, and protective agents that enable direct PCR amplification. This parameter optimization allows crude samples to be amplified directly without expensive purification, maintaining detection sensitivity through chemical optimization rather than physical separation
4Measurement precision
If extraction steps are performed during high demand periods, then detection accuracy is maintained, but supply shortages exacerbate the limitations
Solution Approach 1:
The invention removes the extraction step from the workflow, thereby eliminating dependence on extraction kits and consumables that are in short supply during high demand periods. By enabling direct amplification from crude samples using a simple buffer system, the method bypasses the supply chain constraints that affect extraction reagents and materials
Solution Approach 2:
The unique buffer composition serves multiple functions that previously required separate specialized reagents: it preserves nucleic acids, enables direct amplification, and maintains detection sensitivity. This multi-functional buffer system replaces multiple specialized extraction consumables with a single universal reagent that works across different sample types and PCR applications
Data Source
AI summary
The invention provides compositions and methods allowing for rapid, accurate, robust, and low-cost diagnosis of infectious diseases via extraction-free, direct PCR techniques.